Source: Health Products Regulatory Authority (IE) Revision Year: 2018 Publisher: Amdipharm Limited,Temple Chambers, 3 Burlington Road, Dublin 4, Ireland
Valoid is indicated in adults and children aged 6 years and over for the prevention and treatment of nausea and vomiting, including:
Valoid may be of value in relieving vomiting and attacks of vertigo associated with Meniere’s disease and other forms of vestibular disturbance.
To prevent motion sickness Valoid Tablets should be taken about one to two hours before departure.
There have been no specific studies of Valoid Tablets in the elderly. Experience has indicated that normal adult dosage
is appropriate.
Children less than 6 years of age: Valoid Tablets are not recommended for children less than 6 years of age.
Children 6 to 12 years of age: 25 mg orally, which may be repeated up to three times a day.
Children over 12 years of age: 50 mg orally, which may be repeated up to three times a day.
50 mg orally, which may be repeated up to three times a day.
Oral.
Symptoms of acute toxicity from cyclizine arise from peripheral anticholinergic effects and effects on the central nervous system.
Peripheral anticholinergic symptoms include dry mouth, nose and throat, blurred vision, tachycardia and urinary retention. Central nervous system effects include drowsiness, dizziness, incoordination, ataxia, weakness, hyperexcitability, disorientation, impaired judgement, hallucinations, hyperkinesia, extrapyramidal motor disturbances, convulsions, hyperpyrexia and respiratory depression.
An oral dose of 5mg/kg is likely to be associated with at least one of the clinical symptoms stated above. Younger children are more susceptible to convulsions. The incidence of convulsions in children less than 5 years is about 60% when the oral dose ingested exceeds 40mg/kg.
In the management of acute overdosage with Valoid Tablets, gastric lavage and supportive measures for respiration and circulation should be performed if necessary. Convulsions should be controlled in the usual way with parenteral anticonvulsant therapy.
5 years.
Store below 25°C.
Amber glass or polyethylene bottles with polyethylene tamper-evident caps for pack size 100 tablets.
Not all pack sizes may be marketed.
No special requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
